Reven Pharmaceuticals Stock

reven.comHealthcare / Other Healthcare

Reven Pharmaceuticals is a clinical-stage biopharmaceutical company that aims to treat metabolic and vascular diseases. With a mission to target the root cause of disease through innovative pursuits, Reven Pharmaceuticals uses its RJX platform to enhance medicines and improve patient outcomes. They also aim to treat diseases such as endothelial dysfunction, coronary artery disease, critical limb ischemia, and more. Reven Pharmaceuticals was founded by Brian Denomme and Peter Lange in 1999 and is headquartered in Denver, CO.

Register To Buy and Sell Shares

For more details on financing and valuation for Reven Pharmaceuticals, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Reven Pharmaceuticals’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Reven Pharmaceuticals.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Peter Lange
Co - Founder & CEO
Brian Denomme
Co - Founder & President
Michael Volk
Co - Founder & CSO

Reven Pharmaceuticals’ stock FAQs


Can you buy Reven Pharmaceuticals’ stock?

Reven Pharmaceuticals is not publicly traded on NYSE or NASDAQ in the U.S. To buy Reven Pharmaceuticals’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Can you sell Reven Pharmaceuticals’ stock?

Yes, you can sell stock of a private company like Reven Pharmaceuticals. Forge can help you sell your Reven Pharmaceuticals stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.

What is Reven Pharmaceuticals’ stock price?

Reven Pharmaceuticals is a privately held company and therefore does not have a public stock price. However, you may access Reven Pharmaceuticals’ private market stock price with Forge Data.

What is Reven Pharmaceuticals’ stock ticker symbol?

Reven Pharmaceuticals does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.
Updated on: Jul 17, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.